• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1998 Fiscal Year Final Research Report Summary

Pharmacokinetic Evaluation of First-Pass Effect of Enantiomer

Research Project

Project/Area Number 09672187
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Physical pharmacy
Research InstitutionKYOTO UNIVERSITY

Principal Investigator

YAMAOKA Kiyoshi  Graduate School of Pharmaceu-Science, Kyoto University Associate Professor, 薬学研究科, 助教授 (50109013)

Project Period (FY) 1997 – 1998
KeywordsEnantiomorph / Intestinal Metabolism / First-Pass Effect / Method of PS-DD / Hepatic Disposition / Intestinal Absorption / Systemic Disposition
Research Abstract

Semotiadil and levosemotiadil which are R- and S-enantiomers, respectively, show different physiological activity and pharmacokinetics. By a perfusion experiment the hepatic recovery ratios, FH, of semotiadil and levosemotiadil were 2% and 10%, respectively, which demonstrates that R-enantiomer was extensively eliminated though the rat liver. The mean transit time tH of semotiadil and levosemotiadil were 0.15min and 0.20min, respectively, which were statistically different. The extent of distribution of S-isomer was significantly greater than that of R-isomer. 5'-deoxy-5-fluorouridine (DFUR) is a prodrug of 5'-fluorouracil(5-FU). 5-FU is generated from DFUR in the intestinal wall. Therefore, these two drugs are adopted as a drug model pair for the intestinal metabolism. When DFUR was administered orally to a conscious rat, 65% of DFUR administered as intact form and 7% of DFUR was found as 5-FU in the portal vein. The mean absorption times of these two drugs were almost the same, which means that 5-FU generated from DFUR was further extensively eliminated in the intestinal wall. Another experiment by coadministration of DFUR and uridine demonstrates that uridine inhibited extensively the degradation of 5-FU generated from DFUR.BOF-4272 is the racemic mixture which consists of R- and D-enantiomers. In perfusion experiments at 37oC and 4oC by changing the perfusate BSA concentration, R-isomer is more extensively eliminated than S-isomer in the present of BSA and at 37oC.The extent of elimination was the same between R- and S-isomer in the absence of perfusate BSA or at 4oC, The experiment at 4oC demonstrated that there is a equilibrium distribution phase which is difficult to be observed at 37oC.The efficient hepatic elimination of BOF-4272 was explained by this equilibrium distribution phase.

  • Research Products

    (12 results)

All Other

All Publications (12 results)

  • [Publications] 山岡, 清: "An Analysis Program Based on Finite Element Methol, MCLTI(FFM), for Eucluation of Dose Paperds." J.Pkarm. Sci.in press. (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 山岡, 清: "Effect of Pertbarbifal Anesthesia On Intestinal Absorptun and Hepatic First Effect on Oxacillr" J.Pharm. Pharmacology. in press. (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 山岡, 清: "A Pharmacokinetic Analysis Program Based On Tomknin-Series Model, MULTI(TTS)Lor Evaluation." Biol. Pharm. Bull.21. 1338-1343 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 山岡, 清: "Effact of Coadministration of Uniding on Intestinal First-Pass Metabolism of 5'-Pery-5-Fluoroumiders." Pharm. Res.15. 1007-1011 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 山岡, 清: "Simultanous Evaluating of Intestinal Absorption and Hepatic Extraction of 5-Fluorouracil" Biol. Pharm. Bull. 20. 1313-1316 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 山岡, 清: "New Eucluation Method for Intestinal Metabolism by Portal-Systemic Concetration Pifforce Using 5'- DFV〓" J.Pharm. Sa.86. 1269-1272 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kazuya Fukumura, Kiyoshi Yamaoka, Mitsuo Higashimori and Terumichi Nakagawa: "An Analysis Program Based on Finite Element Method, MULTI (FEM), for Evaluation of Dose-dependent Local Disposition of Drug in Liver" J.Pharm.Sci. (in press). (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Sinya.Ueda, Kiyoshi Yamaoka, Terumichi Nakagawa: "Effect of Pentobaribital Anesthesia on Intestinal Absorption and Hepatic First-Pass Metabolism of Oxacillin Evaluated by Portal-Systemic Concentration Difference" J.Pharm.Pharmacol.(in press). (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kazuya FUKUMURA,Kiyoshi YAMAOKA,Mitsuo HIGASHIMORI and Terumichi NAKAGAWA: "A Pharmacokinetic Analysis Program Based on Tankin-Series Model, MULTI (TIS), for Evaluation of Capacity-limited Local Disposition" Biol.Pharm.Bull.21. 1338-1343 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yoneichi Sawai, Kiyoshi Yamaoka and Terumichi Nakagawa: ""Effect of Coadministered Uridine on Intestinal First-Pass Metabolism of 5'-Deoxy-5-Fluorouridine in Conscious Rats-An Evaluation by Method of Portal-Systemic Concentration Difference-"" Pharm.Res. 15. 1007-1011 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yoneichi SAWAI,Kiyoshi YAMAOKA,Takashi ITO and Terumichi NAKAGAWA: "Simultaneous Evaluation of Intestinal Absorption and Hepatic Extraction of 5-Fluorouracil Using Portal-Systemic Concentration Difference by Short-Period Double Dosing in Single Conscious Rat" Biol.Pharm.Bull.20. 1313-1316 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yoneichi Sawai, Kiyodhi Yamaoka, Arisa Takemura and Terumichi Nakagawa: "New Evaluation Method for Intestinal Metabolism by Portal-Systemic Concentration Difference Using 5'-Deoxy-5-Fluoroudineas Model Drug in Concsious Rat" J.Pharm.Sci.86. 1269-1272 (1997)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1999-12-08  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi